Literature DB >> 20467314

Refractive surgery after corneal transplant.

Jocelyn Kuryan1, Prabjot Channa.   

Abstract

PURPOSE OF REVIEW: Ametropia and astigmatism following successful penetrating keratoplasty can seriously impact a patient's quality of vision. Similar limitations can result following anterior lamellar keratoplasty (ALK) and Descemet's stripping endothelial keratoplasty (DSEK). These patients often suffer from aniseikonia and can be intolerant of spectacles and contact lenses. Refractive surgery can correct both ametropia and astigmatism following corneal transplantation and improve a patient's final visual outcome. The same methods used to correct naturally occurring refractive errors are being used with increasing success in patients who have undergone corneal transplants. RECENT
FINDINGS: Many refractive options are available to treat ametropia following penetrating keratoplasty. Incisional keratotomies have been employed to treat high amounts of astigmatism. Photorefractive keratectomy (PRK) and laser in-situ keratomileusis (LASIK) are also used to treat myopia, hyperopia and astigmatism. LASIK has been shown to have an overall better outcome compared to PRK; however, the use of mitomycin-C with PRK has improved results. Phakic and pseudophakic piggyback intraocular lenses are also being used to treat high degrees of ametropia and astigmatism; however, the long-term results are somewhat limited.
SUMMARY: Refractive surgery can improve the final visual outcome of patients who have undergone successful corneal transplantation. Currently available modalities provide many options for patients who are intolerant of spectacles and contact lenses. Continued advances and research will enable surgeons to optimize visual quality in postkeratoplasty patients.

Entities:  

Mesh:

Year:  2010        PMID: 20467314     DOI: 10.1097/ICU.0b013e32833a9abb

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  8 in total

1.  Customized photorefractive keratectomy to correct high ametropia after penetrating keratoplasty: A pilot study.

Authors:  Giuseppe De Rosa; Rosa Boccia; Carmine Santamaria; Lorenzo Fabbozzi; Luigi De Rosa; Michele Lanza
Journal:  J Optom       Date:  2014-08-21

2.  Development of biomedical publications on ametropia research in PubMed from 1845 to 2010: a bibliometric analysis.

Authors:  Chang-Tai Xu; Shan-Qu Li; Yong-Gang Lü; Bo-Rong Pan
Journal:  Int J Ophthalmol       Date:  2011-02-18       Impact factor: 1.779

3.  Polypseudophakia for cataract surgery: 10-year follow-up on safety and stability of two poly-methyl-methacrylate (PMMA) intraocular lenses within the capsular bag.

Authors:  A Gomaa; R M H Lee; C S C Liu
Journal:  Eye (Lond)       Date:  2011-05-13       Impact factor: 3.775

Review 4.  Refractive surgery after deep anterior lamellar keratoplasty: a review of the literature.

Authors:  Belén Alfonso-Bartolozzi; Irene Martínez-Alberquilla; Begoña Baamonde; Luis Fernández-Vega-Cueto; José F Alfonso; David Madrid-Costa
Journal:  Int Ophthalmol       Date:  2022-09-09       Impact factor: 2.029

5.  Implantation of a customized toric intraocular lens for correction of post-keratoplasty astigmatism.

Authors:  S Srinivasan; D S J Ting; D A M Lyall
Journal:  Eye (Lond)       Date:  2013-01-25       Impact factor: 3.775

6.  Femtosecond laser refractive surgery after descemet stripping-automated endothelial keratoplasty.

Authors:  Simon Sheung Man Fung; Alfonso Iovieno; Vijay Shanmuganathan; Vicenzo Maurino
Journal:  Case Rep Ophthalmol Med       Date:  2012-04-18

Review 7.  Corneal surgery in keratoconus: which type, which technique, which outcomes?

Authors:  Francisco Arnalich-Montiel; Jorge L Alió Del Barrio; Jorge L Alió
Journal:  Eye Vis (Lond)       Date:  2016-01-18

Review 8.  Epithelial ingrowth following laser in situ keratomileusis (LASIK): prevalence, risk factors, management and visual outcomes.

Authors:  Darren Shu Jeng Ting; Sathish Srinivasan; Jean-Pierre Danjoux
Journal:  BMJ Open Ophthalmol       Date:  2018-03-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.